Sanggayan, Jerald L.

HRN: 27-44-11  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/05/2025
CEFUROXIME 1.5GM (VIAL)
07/05/2025
07/11/2025
IVT
365mg
Q8H
T/C Nephrotic Syndrome
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: